$QNT

BHATIA MANISH H purchased $1.2M of QNT

BHATIA MANISH H purchased 20,000 shares of Quantinuum Inc. (QNT) at $60.00 ($1.20M total) on 2026-06-05.

Original reporting
SEC EDGAR · BHATIA MANISH H
Published Jun 8, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 8, 2026, 8:32 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$QNT
Bullish
low confidence
Mentioned
$QNT
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$QNTBullishLow
01

Why it matters

The disclosure adds incremental sentiment information but does not introduce new company fundamentals (no earnings, guidance, contract, or regulatory action).

02

Market read

Traders may treat the filing as a small positive sentiment datapoint, but it is unlikely to drive a major repricing without additional catalysts.

03

What to watch

No 10b5-1 plan is cited, but the article also provides no context on prior trading patterns, option exercises, or whether the director’s compensation/vesting schedule drove the purchase.

Relevance 7/10Novelty 6/10Timing: Filed 2026-06-08 (covers purchase dated 2026-06-05).

Background

The article reports a Quantinuum (QNT) insider ownership change via SEC Form 4 (open-market purchase by a director).

Company-level read

Ticker impact

$QNTBullishLow confidence
Context

Director Manish H. Bhatia bought 20,000 shares of Quantinuum (QNT) for $1.2M via an open-market purchase disclosed on Form 4.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and small.

Evidence & confidence

The filing is a Form 4 insider transaction with no accompanying operational/regulatory update; insider buys often have weak standalone price follow-through.

Market effects

No sector read-through; this is a single-company insider transaction without new guidance or product/regulatory developments.

None indicated.

None indicated.

Counterpoint

The buy may reflect diversification or personal liquidity planning rather than a strong forward-looking view; Form 4s are often noisy signals.

Key entities

  • Quantinuum Inc.

    Subject of the Form 4 insider transaction disclosure.

  • BHATIA MANISH H

    Director who purchased 20,000 shares for $1.2M on 2026-06-05.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

HighAI 8/10

Quantinuum explained: quantum computing company and Nasdaq listing

Quantinuum, a quantum computing company, offers trapped-ion quantum computers and software for quantum chemistry, cybersecurity, and machine learning. It operates hardware and software services, targeting enterprise and research customers. The company went public on the Nasdaq in 2026, with Honeywell as a significant shareholder. Quantinuum is unique in controlling both hardware and software development internally.

$NVDAHighAI 9/10

NVIDIA's $108B AI Forecast Boosts Quantum: QNT, QUBT to Gain?

NVIDIA (NVDA) forecasted $108B in fiscal 2027 revenue, driven by AI and data center growth. This highlights infrastructure investments supporting quantum computing, benefiting companies like Quantinuum (QNT) and Quantum Computing Inc. (QUBT). QNT reported 279% YoY revenue growth, while QUBT saw a significant revenue increase and strategic acquisitions. Both companies have strong cash positions and high price targets.

$QUBTMed

Quantum Stocks Face Reality Check: QUBT, QNT Stand Out on 75%+ Upside

Quantum computing stocks face increased scrutiny as investors focus on revenue visibility and commercialization. Quantum Computing Inc. (QUBT) and Quantinuum Inc. (QNT) show commercial momentum, with QUBT reporting $5.6M in Q2 revenue and QNT raising its 2026 revenue outlook. Both stocks have analyst price targets suggesting significant upside. The macroeconomic environment remains challenging with elevated inflation and higher yields.

$CIENMed

Tradr Introduces Leveraged ETFs on Ciena, Quantinuum, Rambus, Tower Semiconductor and TTM Technologies

Tradr ETFs launched five new 2X leveraged ETFs tracking Ciena (CIEN), Quantinuum (QNT), Rambus (RMBS), Tower Semiconductor (TSEM), and TTM Technologies (TTMI). The ETFs aim to deliver 200% of the daily performance of the underlying stocks and are listed on Cboe. Tradr manages $10B in assets across 72 leveraged ETFs, targeting sophisticated investors.